1. Widespread microbial utilization of ribosomal β-amino acid-containing peptides and proteins
- Author
-
Thomas A. Scott, Marjan Verest, Jakob Farnung, Clarissa C. Forneris, Serina L. Robinson, Xinjian Ji, Florian Hubrich, Clara Chepkirui, Daniel U. Richter, Stefanie Huber, Philipp Rust, Alena B. Streiff, Qi Zhang, Jeffrey W. Bode, and Jörn Piel
- Subjects
General Chemical Engineering ,Biochemistry (medical) ,Materials Chemistry ,natural products ,peptides ,proteins ,β-amino acids ,bacteria ,protease inhibitors ,genome mining ,ribosomally synthesized and posttranslationally modified peptides ,ketoamides ,Environmental Chemistry ,General Chemistry ,Biochemistry - Abstract
β-Amino residues are regarded as extremely rare features among ribosomal products. They can be installed by a remarkable non-canonical enzymatic splicing process occurring in some Nif11-type ribosomally synthesized and posttranslationally modified peptide (RiPP) pathways from select cyanobacteria. The functions of the final pathway products remained unknown. Here, a global bioinformatic analysis suggested an unexpectedly broad distribution of ribosomal β-amino acid products in diverse bacterial lineages as well as archaea. Characterization of 27 bacterial splicease-substrate pairs confirmed the modification in all cases. The “spliceotide” products include many previously unrecognized RiPP types as well as proteins, contain 35 to >600 residues, and feature single to multiple α-keto-β-amino acid moieties, with 15 different naturally occurring β units characterized and 20 predicted. Of three tested spliceotides, all exhibited exceptionally potent protease inhibitory activity, providing a potential rationale for the widespread splicease chemistry in prokaryotes and highlighting substantial potential for drug discovery and gene-based biomolecule diversification. ISSN:2451-9294 ISSN:2451-9308
- Published
- 2022